William Falstich | Vice President, Global Supply Chain, Primary Care
Pfizer

Bill Falstich is Vice President of Pfizer’s Primary Care Category Global Supply Chain. His team of 50 colleagues manages supply for some of the world’s largest vaccines, a broad Internal Medicines portfolio, and Pfizer’s Paxlovid antiviral. His team also plays a critical role in the commercialization and market expansion of new products, with many launches planned in the coming years. Bill’s team drives continuous improvement across Pfizer’s Primary Care supply in support of Pfizer’s purpose – delivering breakthroughs that change patients’ lives. This includes aspects of supply chain management such as product strategy and orchestration, product launch management, supply network design and supply issue resolution. Bill began his career with Pfizer in 2001, and since that time has held a number of positions within supply chain management, intercompany operations, logistics and distribution, procurement and business technology. He is a graduate of Penn State University with a BS in Supply Chain and Information Management and earned his MBA from Virginia Commonwealth University. He resides near Collegeville, Pennsylvania with his wife and two sons.

Appearances:

Pre-Congress Workshops - 21st April @ 10:00

BIODEFENSE

Protecting public health from biothreats to pandemics.

What is the progress on new technologies in medical product development?
How our governments are incentivizing (portfolio approach), especially with biotech and industry? What International collaborations are being facilitated?

How our governments are incentivizing (portfolio approach), especially with biotech and industry?

10:10 Melinda Hamer, Operating Partner, GHIC

10:30 BARDA & Sabin: Kelly Warfield, Sabin Vaccine Institute’s President of Research & Development, Sabin Institute

10:50 – 11:50 Panel: Collaboration with industry: the solution for a sustainable posture for biodefence and global health security

Col Matt Clark, Joint Project Manager, CBRN, JPEO-CBRND

Kevin Webb, COO, API Innovation Center

Chan Harjivan, Former Assistant at The White House & Chief Strategy Officer, The Medical Countermeasures Coalition

11:50 – 12:50 Panel: Rapid vaccine development through manufacturing innovation

Moderator: Praneel Jadav, Manager, Infectious Disease Policy, BIO

Mike Stebbins, Manufacturing and Threat Countermeasures Division, ATI

Renee Hart, President & CBO, LumaCyte

Lakshmi Krishnan, Vice President of Research, National Research Council of Canada

1:00 - 2:00 break

2:00 – 3:10 Panel: What are the remaining bottlenecks holding us back from achieving the 100 day mission?

Moderator: Dr Philip Krause, Independent Consultant & Former FDA

William Falstich, VP, Primary Care Category Supply Chain Lead, Pfizer

Dr Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UKHSA

Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University

Marion Gruber, Vice President, Public Health and Regulatory Affairs, IAVI

Kent Kester, Executive Director, Vaccine Research and Development, CEPI

3:10 – 4:10 Panel: International pandemic funding – how can we make it accessible globally?

Moderator: Soazic Elise Wang Sonn, Economist, World Bank Group, Washington D.C.

Dr Seth Berkley, Former CEO, Gavi; Senior Advisor, Pandemic Center at Brown University

Dr Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, African Center of Excellence for Genomics of Infectious Diseases (ACEGID)

Megan Rauscher, Senior Manager, Private Sector Program Lead, ThinkWell

Dr Monique K Mansoura, Executive Director, Global Health Security & Biotechnology, Independent

Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UK Health Security Agency

Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, ACEGID